Milrinone lactate is a non-glycoside, non-catecholamine cardiotonic agent used for short-term intravenous treatment of congestive heart failure; it is also applied in the management of low cardiac output syndrome following cardiopulmonary bypass in cardiac surgery, relief of graft vessel spasm, improvement of cardiac function in heart transplant recipients, anti-inflammatory effects, and enhancement of visceral perfusion.